Expertise in
1
conditions

Anil K. Yadav

Meerut, UP, IN 
Expertise in
1
conditions
Meerut, UP, IN 

Overview

Anil Yadav practices practicing medicine in Meerut, India.

Mr. Yadav is highly rated in 1 condition, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Liposarcoma, Philadelphia-Negative Chronic Myeloid Leukemia, and Breast Cancer.

He is actively involved in clinical research, co-authoring 57 peer reviewed articles.

Gender

Male

Locations

Meerut, UP 250004, India
Other Locations
Kanpur, UP 209305, India
Delhi, DL, India
Lucknow, UP 226025, India
Varanasi, UP, India
Dr B R Ambedkar National Institute of Technology Jalandhar
Jalandhar, PB 144008, India
Guwahati, AS 781006, India
Kanpur, JK, India
Hamirpur, JK 177005, India
Gurgaon, HR, India
HBCH & MPMMMCH
Varanashi, India
New Delhi, DL, India

Frequently Asked Questions about Anil K. Yadav

Is Anil K. Yadav a top-rated expert for Large-Cell Immunoblastic Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Anil K. Yadav is classified as an Advanced expert for Large-Cell Immunoblastic Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Yadav's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile